Results
9
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
9 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
UNHH34 | R$45.72 | 1.4% | 22.1% | R$472.1b | R$56.67 | PE33x | E21.5% | 1.6% | ||
D1EX34 | R$9.62 | -3.1% | -19.8% | R$31.7b | R$11.42 | PE46.5x | E16.1% | n/a | ||
P2NB34 | R$50.05 | 1.6% | n/a | R$9.3b | R$53.66 | PE268.8x | E35.4% | n/a | ||
RDOR3 | R$25.15 | -0.5% | -10.2% | R$56.4b | R$39.88 | PE15.6x | E17.4% | 1.2% | ||
H1SI34 | R$209.09 | 0% | n/a | R$8.6b | R$226.47 | PE27.4x | E26.7% | n/a | ||
N2AR34 | R$50.94 | 0% | n/a | R$4.1b | R$64.53 | PS12.2x | E88.1% | n/a | ||
HAPV3 | R$2.10 | -5.0% | -50.8% | R$15.7b | R$5.51 | PS0.6x | E45.1% | n/a | ||
CLOV34 New | R$20.10 | 0.5% | 339.8% | R$1.6b | R$28.56 | PS0.8x | E57.0% | n/a | ||
A2HC34 | R$16.93 | 0% | n/a | R$974.7m | R$24.05 | PS0.3x | E107.1% | n/a |